2009. A Phase II international, multicenter study of oral panobinostat (LBH589) in patients with refractory cutaneous T-cell lymphoma. Hematology Meeting Reports (formerly Haematologica Reports). 2, 5 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i5.725.